The American Society of Cataract and Refractive Surgery Foundation Report issue

Foundation

Organization Overview

First Clinical Trial
2010
NCT01107964
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Active Ingredients

Drugs in Other Trials (1)

icosapent ethyl (vascepa) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 1